ATC Group: R06AX27 Desloratadine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R06AX27 in the ATC hierarchy

Level	Code	Title
`1`	R	Respiratory system
`2`	R06	Antihistamines for systemic use
`3`	R06A	Antihistamines for systemic use
`4`	R06AX	Other antihistamines for systemic use
`5`	R06AX27	Desloratadine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	5 mg

Active ingredients in R06AX27

Active Ingredient
Desloratadine
Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H₁-receptor antagonist activity. After oral administration, desloratadine selectively blocks peripheral histamine Η₁-receptors because the substance is excluded from entry to the central nervous system.

Related product monographs

Document	Type	Information Source
AERIUS Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)
DASERGIN Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
DASSELTA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)
Neoclarityn 5 mg film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)